CCL5 and Parkinson disease: CCL5, a well-known immunoinflammatory chemokine, can promote the migration of Th17 cells to the SN, and the destruction of the BBB makes this process easier, which further aggravates the inflammatory response of DA neurons in the SN and the death of DA neurons and further promotes the progression of PD pathology.